Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxenda Feasibility in Forensic Psychiatry
NCT04781998Phase 4Completed
- Start
- Jul 2021
- Primary completion
- Jul 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, Overweight. Started Jul 2021; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT04781998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04781998.